J Ignacio Herrero
Overview
Explore the profile of J Ignacio Herrero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miguel V, Rey-Serra C, Tituana J, Sirera B, Alcalde-Estevez E, Herrero J, et al.
Redox Biol
. 2023 Nov;
68:102957.
PMID: 37977043
Progressive respiratory failure is the primary cause of death in the coronavirus disease 2019 (COVID-19) pandemic. It is the final outcome of the acute respiratory distress syndrome (ARDS), characterized by...
2.
Rey-Serra C, Tituana J, Lin T, Herrero J, Miguel V, Barbas C, et al.
Life Sci Alliance
. 2023 Jul;
6(10).
PMID: 37487638
Tubulointerstitial fibrosis is the common pathological substrate for many etiologies leading to chronic kidney disease. Although perturbations in the circadian rhythm have been associated with renal disease, the role of...
3.
Colmenero J, Tabrizian P, Bhangui P, Pinato D, Rodriguez-Peralvarez M, Sapisochin G, et al.
Transplantation
. 2021 Dec;
106(1):e30-e45.
PMID: 34905760
De novo malignancies (DNMs) following liver transplantation (LT) have been reported as 1 of the major causes of late mortality, being the most common cause of death in the second...
4.
Miguel V, Tituana J, Herrero J, Herrero L, Serra D, Cuevas P, et al.
J Clin Invest
. 2021 Jan;
131(5).
PMID: 33465052
Chronic kidney disease (CKD) remains a major epidemiological, clinical, and biomedical challenge. During CKD, renal tubular epithelial cells (TECs) present a persistent inflammatory and profibrotic response. Fatty acid oxidation (FAO),...
5.
Fierro-Fernandez M, Miguel V, Marquez-Exposito L, Nuevo-Tapioles C, Herrero J, Blanco-Ruiz E, et al.
FASEB J
. 2020 Jan;
34(1):410-431.
PMID: 31914684
MicroRNAs (miRNAs) regulate gene expression posttranscriptionally and control biological processes (BPs), including fibrogenesis. Kidney fibrosis remains a clinical challenge and miRNAs may represent a valid therapeutic avenue. We show that...
6.
Frutos M, Galan-Chilet I, Goedeke L, Kim B, Pardo-Marques V, Perez-Garcia A, et al.
Mol Cell Biol
. 2019 Sep;
39(22).
PMID: 31501273
Brain insulin resistance is a key pathological feature contributing to obesity, diabetes, and neurodegenerative disorders, including Alzheimer's disease (AD). Besides the classic transcriptional mechanism mediated by hormones, posttranscriptional regulation has...
7.
de la Garza R, Sarobe P, Merino J, Lasarte J, DAvola D, Belsue V, et al.
Transpl Immunol
. 2015 Jul;
33(2):110-6.
PMID: 26225458
Unlabelled: Several studies have shown that some liver transplant recipients may tolerate immunosuppression withdrawal. Mechanisms and biomarkers of tolerance are not well known. Methods: Twenty-four LT patients with immunosuppression side-effects...
8.
Cuervas-Mons V, Herrero J, Gomez M, Gonzalez-Pinto I, Serrano T, Mata M, et al.
Clin Transplant
. 2015 May;
29(8):667-77.
PMID: 25924549
The aim of this study was to evaluate the impact of a steroid-free regimen with tacrolimus and mycophenolate mofetil (modified therapy) vs. a standard regimen of tacrolimus and steroids on...
9.
Fernandez-Ros N, Inarrairaegui M, Paramo J, Berasain C, Avila M, Chopitea A, et al.
Liver Int
. 2014 May;
35(5):1590-6.
PMID: 24836705
Background & Aims: Radioembolization may rarely induce liver disease resulting in a syndrome that is similar to veno-occlusive disease complicating bone marrow transplantation where inflammation, endothelial cell activation and thrombosis...
10.
Roman A, Manito N, Campistol J, Cuervas-Mons V, Almenar L, Arias M, et al.
Transplant Rev (Orlando)
. 2014 Mar;
28(2):84-91.
PMID: 24602805
Transplant recipients receiving immunosuppressive therapy are at increased risk of active cytomegalovirus (CMV) infection and disease. Without appropriate prophylaxis, as many as 80% of solid organ transplant recipients may experience...